Platelet-rich plasma has been a staple of aesthetic and hair restoration medicine for over a decade. Exosome therapy is the newer arrival, and the two are increasingly discussed together, sometimes as competitors, sometimes as complements. Patients ask clinics which is "better." The honest answer is that they are different tools built from different source material, and the right one depends on what a clinic and patient are trying to achieve.
What PRP is
Platelet-rich plasma is prepared from a patient's own blood, drawn on the day of treatment and spun in a centrifuge to concentrate platelets, which are then re-injected or applied topically, often alongside microneedling. Because it is autologous (from the patient's own body), it carries no risk of an immune reaction to donor material, and it has a long track record in orthopaedics, hair restoration, and facial rejuvenation.
Its growth factor content, however, varies by the individual: age, health status, and even time of day can affect platelet concentration and the resulting growth factor yield. Two PRP preparations from the same patient on different days are not guaranteed to be identical.
What exosome therapy is
Exosome preparations are manufactured in a laboratory from stem cells cultured from donor tissue, most commonly umbilical cord (Wharton's jelly), and are allogeneic (from a donor, not the patient). Because they are manufactured rather than drawn from the patient in the room, they can be quantified and standardised: a given vial's exosome count and growth factor concentrations can be documented and held consistent from batch to batch, something PRP's biology does not allow.
They also require no blood draw and no centrifuge, which changes the logistics of a treatment session considerably, though it introduces its own considerations around sourcing, donor screening, and manufacturing standards that a clinic should verify.
Key differences at a glance
Where each tends to be used
PRP has the longer clinical history in hair restoration and orthopaedic applications, and many practitioners default to it for that reason. Exosome therapy is more often discussed in the context of skin rejuvenation, scalp treatments, and as a post-procedure recovery aid following microneedling or laser treatments, where its ready-to-use format and documented signalling profile are practical advantages.
Can they be combined?
Some clinics use PRP and exosome products in the same protocol, on the reasoning that they carry overlapping but not identical signalling molecules. Whether combining them makes sense for a given patient and protocol is a clinical decision that belongs with the treating practitioner, informed by the patient's history and goals rather than by which product a given supplier is promoting.
What to check before choosing a supplier
If a clinic decides to add exosome therapy to its offerings, the product itself carries the same scrutiny any injectable or topical regenerative product should: documented exosome count, disclosed tissue source, a quantified bioactive profile, and GMP-compliant manufacturing. Hakke publishes this documentation for both our Revival Serum and Scalp Care platforms, manufactured in Japan under Class 100 cleanroom conditions. See the full mechanism on our exosome science page.